Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uniflu CoughStop Syrup is an over-the-counter (OTC) cough syrup developed and marketed by Phoenix Laboratories. Formulated as a medical device, it is designed to soothe dry, tickly, and irritating coughs and reduce irritation of the oral cavity and throat. The syrup contains natural active ingredients, including white marshmallow root macerate, honey, and propolis extract. Marshmallow root mucilage acts by coating the oral and pharyngeal mucosa, creating a protective barrier that relieves dryness and irritation. It is suitable for adults and children from one year of age.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Uniflu CoughStop Syrup.